Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-501,000
Closed -$15.2M 10560
2025
Q4
$15.2M Buy
501,000
+195,200
+64% +$4.79M ﹤0.01% 2864
2025
Q3
$6.05M Hold
305,800
﹤0.01% 3839
2025
Q2
$7.62M Buy
305,800
+80,800
+36% +$1.82M ﹤0.01% 3405
2025
Q1
$5.27M Sell
225,000
-175,000
-44% -$5.07M ﹤0.01% 3730
2024
Q4
$11.2M Hold
400,000
﹤0.01% 2919
2024
Q3
$8.15M Sell
400,000
-100,000
-20% -$2.24M ﹤0.01% 2562
2024
Q2
$14.8M Sell
500,000
-100,000
-17% -$2.87M ﹤0.01% 1919
2024
Q1
$18.3M Buy
600,000
+274,900
+85% +$7.76M ﹤0.01% 1768
2023
Q4
$7.61M Buy
325,100
+225,100
+225% +$5.44M ﹤0.01% 2342
2023
Q3
$2.96M Hold
100,000
﹤0.01% 3071
2023
Q2
$3.53M Buy
100,000
+70,000
+233% +$1.96M ﹤0.01% 2928
2023
Q1
$722K Sell
30,000
-13,600
-31% -$315K ﹤0.01% 4392
2022
Q4
$970K Sell
43,600
-213,200
-83% -$4.94M ﹤0.01% 4102
2022
Q3
$6.1M Hold
256,800
﹤0.01% 2176
2022
Q2
$5.97M Hold
256,800
﹤0.01% 2221
2022
Q1
$10.5M Buy
256,800
+215,200
+517% +$11.2M ﹤0.01% 1899
2021
Q4
$3.17M Buy
+41,600
New +$3M ﹤0.01% 3305

Other funds holding CFLT

UBS Group's CFLT Position: Q1 2026 in Review

UBS Group sold out of Confluent (CFLT) in Q1 2026, closing a stake of 12,864,520 shares — an estimated $389M sold.

UBS Group first reported a position in CFLT in Q3 2021 and held it in 18 quarters. The position peaked at $389M in Q4 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • UBS Group reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 12,864,520 Confluent shares in Q1 2026, an estimated $389M.
  • UBS Group first reported a position in Confluent in Q3 2021 and held it in 18 quarters.
  • UBS Group's Confluent position peaked at $389M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.